Skip to main content
. 2011 Aug 10;6(8):e23092. doi: 10.1371/journal.pone.0023092

Figure 4. Anti-gp130 levels.

Figure 4

Anti-gp130 levels post-SIVmacC8 vaccination and post SIVsmE660 challenge determined by binding antibody ELISA, (day 0 represents day of SIVsmE660 challenge) shown for Groups A, B and C. Group A shows anti-SIVmacC8 gp130 levels for 20 weeks prior to SIVsmE660 challenge (at day 0) with an anamnestic response detected in B204. Panel B shows anti-gp130 responses in Group B (3 week vaccinates) and Group C (SIVsmE660 naïve challenge controls) respectively.